My Background

I am a consultant to the Biotechnology & Pharmaceutical industries. Before I retired from Bristol-Myers Squibb in 1994, I spent 34 years in various positions, including serving as Associate Director of the Squibb Institute for Medical Research, Vice President of Development, Vice President, Scientific Liason, Vice President of Licensing, and Vice President of Business Development and Planning for the pharmaceutical division of Bristol-Myers Squibb.

I have held advisory positions at the Unviersity of Pittsburgh (where I attained my Ph.D in Pharmacology in 1960), Rutgers College of Pharmacy, and Princeton University.

I was Chairman of the Board of Magainin Pharmaceuticals (now called Genaera) and am currently Chairman of Phyton, Inc. In addition, I am a director of 11 other companies: Biocryst Pharmaceuticals, Diacrin, Avigen, Synaptic Pharmaceuticals, Phyton, 3-Dimensional Pharmaceuticals, Nitromed, Immunicon, Palatin Technologies, Epigenesis, and Dov Pharmaceuticals.

I am the winner of the A.E. Bennett Neuropsychiatric Research Award and one of the winners of the American Heart Association Discovery Award for work on the development of angiotensin converting enzyme inhibiters.

I have also provided research, development and business advice to large pharamceutical companies, small and large biotechnology companies, venture capital firms, and law firms.